How have BFRIW shares performed in 2024?

Biofrontera's stock was trading at $0.01 at the beginning of 2024. Since then, BFRIW stock has increased by 500.0% and is now trading at $0.06. View the best growth stocks for 2024 here .

How do I buy shares of Biofrontera?

Shares of BFRIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BFRIW

Biofrontera (BFRIW) Stock Price, News & Analysis

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)

Free BFRIW Stock Alerts

$0.06

0.00 (0.00%)

(As of 04/26/2024 ET)

Compare

Today's Range: $0.06
▼
$0.06
50-Day Range: $0.02
▼
$0.07
52-Week Range: $0.01
▼
$0.37

Volume: 400 shs
Average Volume: 8,455 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Social Media

Get Biofrontera alerts:

Ad Colonial Metals

The Gold Grab of the Century

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.

About Biofrontera

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

BFRIW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BFRIW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive BFRIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biofrontera and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: NASDAQ:BFRIW
CUSIP: N/A
CIK: 1858685
Web: www.biofrontera-us.com
Phone: 781-245-1325
Fax: N/A
Employees: 83
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $34.07 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Dr. Hermann Luebbert Ph.D. (Age 68)
CEO, President & Executive Chairman
Comp: $733.23k
Mr. Eugene Frederick Leffler III (Age 39)
Chief Financial Officer
Comp: $378.58k
Ms. Erica F. Gates CPA
M.B.A., Senior Director of Finance & Principal Accounting Officer
Mr. Jon Lyons M.B.A.
Ph.D., Vice President of Scientific & Medical Affairs
Ms. Alycia Torres
Vice President of Administration
Mr. Daniel Hakansson J.D.
General Counsel & Head of Compliance
Ms. Samantha Widdicombe
Senior Director of Strategic Accounts & Communications
Mr. Mark Baldyga
Vice President of Sales & Marketing

Key Competitors

View All Competitors

BFRIW Stock Analysis - Frequently Asked Questions

How have BFRIW shares performed in 2024?: Biofrontera's stock was trading at $0.01 at the beginning of 2024. Since then, BFRIW stock has increased by 500.0% and is now trading at $0.06.
View the best growth stocks for 2024 here.
How do I buy shares of Biofrontera?: Shares of BFRIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BFRIW) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial